Reports
Sale
Global Healthcare Distribution Market Size, Share, Forecast: By Type: Pharmaceutical Product Distribution Services, Medical Device Distribution Services, Biopharmaceutical Product Distribution Services; By End Use: Retail Pharmacies, Hospital Pharmacies, Others; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
Global Healthcare Distribution Market Size
The global healthcare distribution market reached a value of approximately USD 935.46 billion in 2023. The market is further estimated to grow at a CAGR of 7.1% in the forecast period of 2024-2032.
Healthcare Distribution Market Outlook
- Eurostat figures indicate Germany (12.8%) and France (12.2%) led healthcare spending relative to GDP among EU nations in 2020.
- In 2022, the US healthcare spending surged 4.1% to $4.5 trillion, as per the National Health Expenditure Account (NHEA).
- The UK Government data highlights 2,400 hospitals in the UK, which adds to the rising demand for healthcare supplies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Healthcare Distribution Market Growth
The market for healthcare distribution is propelled by the increasing importance of generics and the expanding biosimilars and medical equipment sectors, driven by technological advancements. Factors like track and trace solutions, speciality drug dispensing, and biopharmaceutical acceptance aid the market, alongside the rising popularity of generics in developing regions.
Generic drugs are identical to brand-name drugs in every aspect, offering the same benefits and risks. They are cost-effective as they don't incur developmental expenses. A robust distribution system is crucial due to increased demand globally. India alone had 23,581 government hospitals and 22 central government hospitals in 2019.
Key Trends and Developments
E-commerce integration, distribution of personalised medicine, progress in medical equipment, embracing track and trace solutions are the major trends impacting the global healthcare distribution market growth.
March 26, 2024
Sanofi India, in collaboration with Sanofi Healthcare India Private Limited and Cipla, declared an exclusive distribution and marketing deal for Sanofi India's CNS product line.
March 11, 2024
Tecsys Inc., renowned for its supply chain management solutions, had announced Truepill's adoption of its Elite™ Warehouse Management System (WMS). This step aimed to enhance Truepill's distribution capabilities for supporting rapid growth.
January 18, 2024
Sun Pharmaceutical Industries Limited and Bayer had reached an agreement to distribute another brand of Finerenone in India, aiming to mitigate complications in patients with type 2 diabetes-related chronic kidney disease.
November 27, 2023
Tecsys Inc., a renowned provider of supply chain management solutions, introduced Elite™ WMS for Healthcare Distribution, featuring built-in serialized DSCSA support. This aimed to ensure continuous compliance with FDA's DSCSA regulations.
E-commerce integration
Healthcare distribution networks are increasingly integrating e-commerce platforms to streamline procurement and distribution processes, thereby improving accessibility and efficiency in delivering medical supplies and pharmaceuticals.
Distribution of personalised medicine
Distribution systems are adjusting to incorporate personalised medicine, necessitating custom logistics solutions for efficient delivery of tailored treatments to patients globally.
Progress in medical equipment
Technological breakthroughs are driving the advancement of cutting-edge medical equipment, which in turn, is fuelling the growth of the market.
Embracing track and trace solutions
The heightened utilisation of track and trace technologies aims to enhance supply chain transparency and combat the proliferation of counterfeit products through increased monitoring.
Healthcare Distribution Market Trends
The demand for generic drugs and biosimilars is increasing due to their cost-effectiveness and efficacy. Technological advancements are fuelling the development of advanced medical equipment. Track and trace solutions are gaining traction for supply chain transparency. Specialized distribution channels are emerging for dispensing speciality drugs.
Biopharmaceutical acceptance is rising for treating various diseases. The global market is expanding, driven by the popularity of generics in developing regions, requiring robust distribution networks for timely delivery.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Healthcare Distribution Industry Segmentation
“Healthcare Distribution Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Pharmaceutical Product Distribution Services
- Over-the-Counter Drugs/Vitamins
- Brand-Name/Innovator Drugs
- Generic Drugs
- Medical Device Distribution Services
- Biopharmaceutical Product Distribution Services
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Blood and Blood Products
- Others
Market Breakup by End Use
- Retail Pharmacies
- Hospital Pharmacies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Healthcare Distribution Market Share
Retail pharmacies have emerged as a significant end user of healthcare distribution services, especially for pharmaceutical products.
Retail pharmacies, conveniently located in communities, ensure swift access to medications and over-the-counter items, offering patient education, preventive care, and specialised chronic disease management programs for comprehensive healthcare support.
On the other hand, hospital pharmacies are crucial within healthcare institutions, delivering comprehensive care, clinical assistance, formulary oversight, and customised medication solutions, ensuring patient safety and evidence-based practices.
By type, medical device distribution services significantly contribute to the healthcare distribution market revenue. Companies specialise in the distribution of various medical devices, ensuring proficiency in handling, and delivering specialized equipment tailored to specific needs.
Medical device distribution services specialize in managing a broad array of medical equipment, ensuring proficiency, effectiveness, and adherence to regulations, facilitated by advanced inventory management systems for optimal stock levels and efficient operations.
Biopharmaceutical product distribution services excel in maintaining precise temperature control, ensuring regulatory adherence, streamlining supply chain efficiency, and offering specialized handling to ensure the safe transportation and delivery of fragile products.
Leading Manufacturers in the Healthcare Distribution Market
The market players offer pharmaceutical sourcing and distribution services, delivering pharmaceutical products, business solutions, and value-added services that enhance access to healthcare.
McKesson Corporation (MCK)
Founded in 1833, with its headquarters in the United States, McKesson is a globally recognized healthcare firm listed on the NYSE (MCK), delivering pharmaceutical distribution, medical supplies, and healthcare technology solutions.
Cardinal Health (CAH)
Established in 1971, and situated in the United States, Cardinal Health (CAH) is a prominent healthcare services entity listed on the NYSE, specializing in global pharmaceutical and medical products distribution.
AmerisourceBergen Corporation (ABC)
Tracing its roots to 2001, AmerisourceBergen Corporation (ABC), headquartered in Pennsylvania, stands as a Fortune 500 company listed on the NYSE, focusing on pharmaceutical distribution and associated services.
Owens & Minor, Inc. (OMI)
Founded in 1882, with its main offices located in Richmond, Virginia, Owens & Minor, Inc. (OMI) is a healthcare logistics enterprise providing distribution, inventory management, and supply chain solutions.
Other players in the market are Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, and Dakota Drug, Inc., among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Healthcare Distribution Market Analysis by Region
The Asia Pacific region holds a leading position in the healthcare distribution sector, primarily driven by escalating healthcare expenditures.
Asia Pacific's continual advancement in the healthcare technology and the substantial patient populace are poised to fuel the growth of the market.
As per NCBI's 2023 report, sustained governmental initiatives have led to the establishment of a total of 1,030,935 healthcare institutions across mainland China by the conclusion of 2021, comprising 36,570 hospitals and 977,790 primary-level clinics.
North America anticipates notable growth in the healthcare distribution market driven by increased demand for speciality drugs and generics, alongside extensive adoption of advanced technologies like AI and blockchain, enhancing supply chain efficiency.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Our Top Selling Reports
Healthcare Distribution Market Report Snapshots
Healthcare Distribution Market Size
Healthcare Distribution Market Growth
Healthcare Distribution Market Trends
Healthcare Distribution Market Share
Healthcare Distribution Manufacturers
Healthcare Distribution Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Healthcare Distribution Market Analysis
8.1 Key Industry Highlights
8.2 Global Healthcare Distribution Historical Market (2018-2023)
8.3 Global Healthcare Distribution Market Forecast (2024-2032)
8.4 Global Healthcare Distribution Market by Type
8.4.1 Pharmaceutical Product Distribution Services
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Over-The-Counter Drugs/Vitamins
8.4.1.3.2 Brand-Name/Innovator Drugs
8.4.1.3.3 Generic Drugs
8.4.2 Medical Device Distribution Services
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Biopharmaceutical Product Distribution Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Type
8.4.3.3.1 Monoclonal Antibodies
8.4.3.3.2 Vaccines
8.4.3.3.3 Recombinant Proteins
8.4.3.3.4 Blood and Blood Products
8.4.3.3.5 Others
8.5 Global Healthcare Distribution Market by End Use
8.5.1 Retail Pharmacies
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Hospital Pharmacies
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Healthcare Distribution Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Healthcare Distribution Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Healthcare Distribution Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Healthcare Distribution Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Healthcare Distribution Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Healthcare Distribution Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 McKesson Corporation [MCK (NYSE)]
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Cardinal Health [CAH (NYSE)]
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 AmerisourceBergen Corporation [ABC (NYSE)]
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Owens & Minor, Inc. [OMI (NYSE)]
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Morris & Dickson Co. L.L.C.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Priority Healthcare Distribution, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 FFF Enterprises, Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Attain Med
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Dakota Drug, Inc.
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Healthcare Distribution Market: Key Industry Highlights, 2018 and 2032
2. Global Healthcare Distribution Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Healthcare Distribution Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Healthcare Distribution Historical Market: Breakup by End Use (USD Million), 2018-2023
5. Global Healthcare Distribution Market Forecast: Breakup by End Use (USD Million), 2024-2032
6. Global Healthcare Distribution Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Healthcare Distribution Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Healthcare Distribution Market Structure
Key Questions Answered in the Report
The healthcare distribution market was valued at USD 935.46 billion in 2023.
The market is projected to grow at a CAGR of 7.1% between 2024 and 2032.
The market is categorised according to the type, which includes pharmaceutical product distribution services, medical device distribution services and biopharmaceutical product distribution services.
The major market drivers include growing significance of generics, increasing prevalence of chronic diseases, and the expanding biosimilars and medical equipment industries due to the advancement in technology.
The e-commerce integration and the growing demand for personalised medications are expected to be key trends guiding the growth of the market.
Based on the end use, the market is divided into retail pharmacies, hospital pharmacies, and others.
The market is broken down into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The key market players are McKesson Corporation [MCK (NYSE)], Cardinal Health [CAH (NYSE)], AmerisourceBergen Corporation [ABC (NYSE)], Owens & Minor, Inc. [OMI (NYSE)], Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, and Dakota Drug, Inc., among others.
Analyst Review
The global healthcare distribution market attained a value of USD 935.46 billion in 2023, driven by the growing significance of generics and the expanding biosimilars and medical equipment industries due to the advancement in technology. Aided by increasing prevalence of chronic diseases, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 7.1%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the type, the healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services and biopharmaceutical product distribution services. Pharmaceutical product distribution services are further classified as over-the-counter drugs/vitamins, brand-name/innovator drugs and generic drugs. Biopharmaceutical product distribution services are further classified as monoclonal antibodies, vaccines, recombinant proteins, blood and blood products, amongst others. Healthcare distribution can have different end-uses like in retail pharmacies and hospital pharmacies, amongst others. The key players in the above industry include McKesson Corporation [MCK (NYSE)], Cardinal Health [CAH (NYSE)], AmerisourceBergen Corporation [ABC (NYSE)], Owens & Minor, Inc. [OMI (NYSE)], Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, Dakota Drug, Inc., Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER